GGrantIndex
Sort

34,240 grants matching atherosclerosis

Hematopoietic stem cell mutations and ischemic cardio-metabolic disease

$485,033
Kenneth Walsh · University Of Virginia · R01 · FY2020 · HL

Post-DPP Follow-Up Study

$485,006
Neil H. White · Washington University · U01 · FY2013 · DK

Genetic and Genomic Analysis of apoAV

$484,965
University Of Calif-Lawrenc Berkeley Lab · R01 · FY2004 · HL

RANK-RANKL and Vascular Complications in Chronic Kidney Disease

$484,957
Michael E Rosenfeld · University Of Washington · R01 · FY2013 · DK

PREVALENCE &PROGRESSION OF SUBCLINICAL ATHEROSCLEROSIS

$484,904
Rush University Medical Center · R01 · FY2001 · HL

A Macrophage Protein Network Links Obesity and type 2 Diabetes to Atherosclerosis

$484,847
Lev Becker · University Of Chicago · R01 · FY2020 · HL

Structure and Function of Heparin Cofactor II

$484,837
Washington University · R01 · FY2004 · HL

Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The MESA Study

$484,835
Bryan R Kestenbaum · University Of Washington · R01 · FY2013 · HL

MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers

$484,706
Felix W Wehrli · University Of Pennsylvania · R01 · FY2021 · HL

Spatiotemporal Regulation of Organelle Interactions and Metabolism

$484,625
David J Kast · Washington University · R35 · FY2025 · GM

MR evaluation of macro- and micro-vascularity in diabetic peripheral artery disease

$484,590
Mitsue Miyazaki · University Of California, San Diego · R01 · FY2021 · HL

Nlrp3 inflammasome activation in early diabetic retinopathy

$484,500
Jayakrishna Ambati · University Of Virginia · R01 · FY2020 · EY

Post-DPP Follow-up Study

$484,269
University Of California Los Angeles · U01 · FY2003 · DK

Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease

$484,233
Ian H De Boer · University Of Washington · R01 · FY2019 · DK

Diabetes Prevention Program Outcomes Study - Phase 2

$484,221
David A Ehrmann · University Of Chicago · U01 · FY2011 · DK

Role of the 5-Lipoxygenase Pathway in Atherosclerosis

$483,993
Hooman Allayee · University Of Southern California · R01 · FY2007 · HL

Vascular specific ACE expression and atherosclerosis

$483,957
William Robert Taylor · Emory University · P01 · FY2007 · HL

Hyperglycemia, Aldose Reductase and Murine Atherosclerosis

$483,947
Ira Jay Goldberg · Columbia University Health Sciences · P01 · FY2010 · HL

Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans

$483,871
Nathan Oliver Stitziel · University Of Washington · P01 · FY2020 · HL

Mechanisms of action of drugs that prevent experimental diabetic retinopathy

$483,863
Mara Lorenzi · Schepens Eye Research Institute · R01 · FY2010 · EY

B cell anergy, modified LDL uptake, and atherosclerosis

$483,862
Elena V Galkina · Eastern Virginia Medical School · R01 · FY2020 · HL

B cell anergy, modified LDL uptake, and atherosclerosis

$483,862
Elena V Galkina · Eastern Virginia Medical School · R01 · FY2019 · HL

B cell anergy, modified LDL uptake, and atherosclerosis

$483,862
Elena V Galkina · Eastern Virginia Medical School · R01 · FY2021 · HL

Cardiovascular Scientist Training Program

$483,858
James N Weiss · University Of California Los Angeles · T32 · FY2016 · HL

Plaque Inflammation and Dysfunctional HDL in AIM-HIGH

$483,730
Kevin D. O'Brien · University Of Washington · R01 · FY2009 · HL